Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Tim, Muilwijk"'
Autor:
Murat Akand, Tim Muilwijk, Ben Van Cleynenbreugel, Thomas Gevaert, Steven Joniau, Frank Van der Aa
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 21-27 (2024)
Non–muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease categorized as low, intermediate, high, or very high risk, for which recurrence and progression rates and thus management strategies differ. Current molecular subclassification o
Externí odkaz:
https://doaj.org/article/3652150134e4497f8e472d50feb16b80
Autor:
Tim Muilwijk, Loïc Baekelandt, Murat Akand, Sofie Daelemans, Koen Marien, Yannick Waumans, Pieter-Jan van Dam, Mark Kockx, Thomas Van den Broeck, Ben Van Cleynenbreugel, Frank Van der Aa, Thomas Gevaert, Steven Joniau
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 67-74 (2024)
Background and objective: The tumor microenvironment (TME) in non–muscle-invasive bladder cancer (NMIBC) plays an important role in the anticancer response. We aimed to identify the prognostic biomarkers in the TME of patients with NMIBC for progre
Externí odkaz:
https://doaj.org/article/6a15f4e11a4e4f86bfac6ff265de9483
Autor:
Daimantas Milonas, Alexander Giesen, Tim Muilwijk, Charlotte Soenens, Gaëtan Devos, Zilvinas Venclovas, Alberto Briganti, Paolo Gontero, R. Jeffrey Karnes, Piotr Chlosta, Frank Claessens, Gert De Meerleer, Wouter Everaerts, Markus Graefen, Giansilvio Marchioro, Rafael Sanchez-Salas, Bertrand Tombal, Henk Van Der Poel, Hendrik Van Poppel, Martin Spahn, Steven Joniau
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 33-37 (2024)
International Society of Urological Pathology grade group 1 (GG 1) prostate cancer (PCa) is generally considered insignificant, with recent suggestions that it should even be considered as “noncancerous”. We evaluated outcomes for patients with G
Externí odkaz:
https://doaj.org/article/c8d0ad4edb444a3cbd022eb478d1fc4d
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Bladder cancer (BC) is the most common malignancy of the urinary tract. About 75% of all BC patients present with non-muscle-invasive BC (NMIBC), of which up to 70% will recur, and 15% will progress in stage and grade. As the recurrence and progressi
Externí odkaz:
https://doaj.org/article/c24b89e763e841ffb37d72a82d5c33a0
Autor:
Christine G.J.I. van Straten, Christien Caris, Marc-Oliver Grimm, Marc Colombel, Tim Muilwijk, Luis Martínez-Piñeiro, Marko M. Babjuk, Levent N. Türkeri, Joan Palou, Anup Patel, Anders S. Bjartell, Wim P.J. Witjes, Antoine G. van der Heijden, Lambertus A.L.M. Kiemeney
Publikováno v:
European Urology Open Science, Vol 56, Iss , Pp 15-24 (2023)
Background: Adverse events induced by intravesical bacillus Calmette-Guérin (BCG) to treat high-grade non–muscle-invasive bladder cancer (NMIBC) often lead to treatment discontinuation. The EAU-RF NIMBUS trial found a reduced number of standard-do
Externí odkaz:
https://doaj.org/article/da507eeb842949a392f422cfef50f3e2
Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer
Autor:
David D’Andrea, Beat Foerster, Surena F. Matin, Ja H. Ku, Tim Muilwijk, Leonardo L. Monteiro, Ross Liao, Firas G. Petros, Philippe E. Spiess, Trinity J. Bivalacqua, Kees Hendricksen, Bas W.G. van Rhijn, Ahmad Shabsigh, Alberto Briganti, Steven Joniau, Wassim Kassouf, Phillip M. Pierorazio, Vitaly Margulis, Andrea Necchi, Shahrokh F. Shariat
Publikováno v:
European Urology Open Science, Vol 19, Iss , Pp 16-19 (2020)
Externí odkaz:
https://doaj.org/article/05e22d7e4bda444aa686da20e2d7194d
Autor:
Tim Muilwijk, Murat Akand, Sofie Daelemans, Koen Marien, Yannick Waumans, Mark Kockx, Loïc Baekelandt, Thomas Van den Broeck, Frank Van der Aa, Thomas Gevaert, Steven Joniau
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257195 (2021)
Fibroblast activation protein-α (FAP) is a transmembrane peptidase and a surrogate marker for cancer-associated fibroblasts (CAFs). FAP has been linked to worse prognosis and therapy resistance in several cancers. We hypothesised that FAP might have
Externí odkaz:
https://doaj.org/article/f0597e3b89774a5bb0703e23b1b04251
Autor:
Thomas Gevaert, Yves-Rémi Van Eycke, Thomas Vanden Broeck, Hein Van Poppel, Isabelle Salmon, Sandrine Rorive, Tim Muilwijk, Frank Claessens, Dirk De Ridder, Steven Joniau, Christine Decaestecker
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0244663 (2020)
The tumour micro-environment (TME) plays a crucial role in the onset and progression of prostate cancer (PCa). Here we studied the potential of a selected panel of TME-markers to predict clinical recurrence (CLR) in PCa. Patient cohorts were matched
Externí odkaz:
https://doaj.org/article/ec82bfb8bd3541ba89838661fe6c91c8
Autor:
Murat Akand, Tim Muilwijk, Jan Cornelissen, Siska Van Bruwaene, Kathy Vander Eeckt, Frederic Baekelandt, Pieter Mattelaer, Raf Van Reusel, Ben Van Cleynenbreugel, Steven Joniau, Frank Van Der Aa
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Purpose: To develop a prospective non-muscle-invasive bladder cancer (NMIBC) data registry by generating NMIBC-specific electronic case report forms (eCRFs) in our institution's electronic patient file system, and to report on the development and imp
Externí odkaz:
https://doaj.org/article/213faaf6441d4fa7a9152cd6bd0e9426
Autor:
Gaëtan Devos, Tim Muilwijk, Yannic Raskin, Victor Calderon, Lisa Moris, Thomas Van den Broeck, Charlien Berghen, Gert De Meerleer, Maarten Albersen, Hendrik Van Poppel, Wouter Everaerts, Steven Joniau
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Introduction: Salvage lymph node dissection (sLND) has been proposed as a treatment option for prostate cancer patients with lymph node (LN) recurrence following radical prostatectomy to delay or avoid palliative androgen deprivation therapy (ADT). H
Externí odkaz:
https://doaj.org/article/d33a69a31ea74897accaffbcb345934f